Regeneron Pharmaceuticals, Inc. (LON:0R2M)

Regeneron Pharmaceuticals Ratios and Metrics

Market cap in millions GBP. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Nov 6, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	51,239	61,217	73,329	63,953	48,764	37,347
Market Cap Growth	-34.74%	-16.52%	14.66%	31.15%	30.57%	20.50%
Enterprise Value	39,069	48,770	63,131	55,414	42,324	34,998
Last Close Price	492.74	561.28	685.79	588.83	468.39	355.28
PE Ratio	15.04	17.37	23.63	17.76	8.18	14.51
PS Ratio	4.83	5.40	7.12	6.33	4.11	6.00
PB Ratio	2.22	2.61	3.60	3.40	3.52	4.63
P/TBV Ratio	2.33	2.72	3.75	3.54	3.52	4.63
P/FCF Ratio	16.31	20.91	24.10	17.42	10.11	25.45
P/OCF Ratio	13.58	17.34	20.33	15.37	9.32	19.48
EV/Sales Ratio	3.61	4.30	6.13	5.49	3.57	5.62
EV/EBITDA Ratio	11.73	13.19	17.28	12.51	6.18	12.25
EV/EBIT Ratio	13.46	14.73	19.00	13.37	6.37	13.04
EV/FCF Ratio	12.44	16.66	20.75	15.09	8.78	23.85
Debt / Equity Ratio	0.09	0.10	0.11	0.12	0.14	0.25
Debt / EBITDA Ratio	0.62	0.63	0.60	0.52	0.29	0.69
Debt / FCF Ratio	0.64	0.80	0.72	0.63	0.41	1.35
Asset Turnover	0.37	0.40	0.42	0.45	0.76	0.53
Inventory Turnover	2.46	2.51	2.51	2.37	2.74	2.26
Quick Ratio	3.19	3.86	4.82	4.16	2.98	2.86
Current Ratio	4.06	4.73	5.69	5.06	3.56	3.63
Return on Equity (ROE)	15.19%	15.95%	16.26%	20.94%	54.21%	31.77%
Return on Assets (ROA)	6.16%	7.31%	8.49%	11.42%	26.39%	14.33%
Return on Capital (ROIC)	7.27%	8.49%	9.76%	13.31%	31.95%	17.95%
Return on Capital Employed (ROCE)	10.70%	12.30%	14.30%	19.20%	41.80%	25.30%
Earnings Yield	6.65%	5.76%	4.23%	5.63%	12.23%	6.89%
FCF Yield	6.13%	4.78%	4.15%	5.74%	9.89%	3.93%
Buyback Yield / Dilution	4.39%	-1.23%	-0.18%	-1.16%	2.52%	-0.44%

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.